Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

NCR Voyix Faces Stock Market Turbulence After Unveiling Preliminary Financial Results

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

NCR Voyix has recently unveiled its preliminary financial results for the fourth quarter and full year of 2023, causing a stir in the stock market.

In Q4, the company suffered a net loss, with earnings per diluted share dropping to $2.25 from $0.15 the previous year. Despite seeing growth in software and services throughout 2023, NCR Voyix‘s Price to Earnings (P/E) Ratio remains in the negative at -3.93, indicating ongoing losses.

The spin-off of NCR Atleos has also played a role in the reported results, as discontinued operations have affected the overall financial picture. As a result, investors have reacted to the disclosed figures by causing a decline in the company’s shares.

As of March 2, 2024, NCR Voyix continues to navigate the challenges presented by its financial performance and market response.

VYX Stock Plunges 21.49% in Tumultuous Day on Market: Potential Rebound in After-Hours Trading

On March 2, 2024, VYX stock had a tumultuous day on the market. The stock closed at $11.47, which was a significant drop of $3.14, or 21.49%, from the previous market close. This put the stock near the bottom of its 52-week range and below its 200-day simple moving average, indicating a bearish trend for the stock.

However, there was a glimmer of hope for VYX investors as the stock rose $0.27 in after-hours trading. While this increase is modest compared to the earlier drop, it does suggest that there may be some buying interest in the stock after the initial sell-off.

VYX Stock Sees Significant Decrease in Revenue and Profitability in 2024

On March 2, 2024, VYX stock experienced a significant decrease in its financial performance compared to the previous year and the last quarter. According to data from CNN Money, the total revenue for VYX was $3.83 billion over the past year, which decreased by 51.17% from the previous year. In the fourth quarter of the year, the total revenue was $963.00 million, representing a decrease of 52.26% from the previous quarter.

Similarly, the net income for VYX was -$422.00 million over the past year, which decreased by 803.33% from the previous year. In the fourth quarter, the net income was -$254.00 million, showing a decrease of 104.84% from the previous quarter.

Furthermore, the earnings per share (EPS) for VYX were -$3.12 over the past year, which decreased by 1099.74% from the previous year. In the fourth quarter, the EPS was -$2.25, indicating a decrease of 147.57% from the previous quarter.

These financial indicators suggest that VYX has been facing challenges in generating revenue and profitability over the past year and the last quarter. Investors and analysts may be concerned about the company’s ability to improve its financial performance and turn the situation around in the future.

Tags: VYX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
COST stock news

Analysts Bullish on Veeva Systems Increase Price Target to 264

Pactiv Evergreen Q4 Financial Results Revenue Decline but Positive Outlook with Restructuring Plan

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Rambus Stock Price Surges with Accelerated Share Repurchase Program

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com